Memphasys: A rare medical device that made it to all the way to commercialisation – and in a huge market! Memphasys Managing Director Dr David Ali on 3AW, 2GB, 4BC & 6PR Bulls N' Bears Report Listen to ASX-listed Memphasys Managing Director Dr David Ali talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ extraordinary IVF medical invention that has just passed a clinical trial with flying colours and is about to go commercial. TO LISTEN TO THE MEMPHASYS LTD AUDI

Leading WA businessman and thoroughbred horse racing identity Bob Peters with his eighth Perth Cup winner, Star Exhibit. Credit: Danella Bevis/The West Australian Bob Peters is used to backing winners – in fact he has bred and owned a great many of them on his way to becoming the king of WA horse racing. Peters, a shrewd WA businessman who built his fortune selling cars, has won WA’s most iconic thoroughbred horse race – the Perth Cup – a record-breaking 11 times. In fact, at

Memphasys Felix bio-separation device Credit: File Australian-based reproductive biotechnology company, Memphasys says it has received a research and development (R&D) tax refund of about $1.3 million from the Australian Tax Office (ATO). The refund has been used to repay an R&D loan to Radium Capital of $849,000 plus interest of $46,621. Management says its net refund of $419,466 will be reinvested in MEM and used as working capital to fund continued development and commerci

Memphasys is helping to create happy families. Credit: File Just when all looked lost for a group of parent hopefuls in India, a groundbreaking piece of Australian medical technology developed by Memphasys has turned their dreams of the pitter-patter of tiny feet into reality. It has been revealed today in a heartwarming development, that after the Sydney-based company’s reproductive biotechnology Felix system led to a baby boy being born in a hospital in India in April, anot

Felix is Memphasys’ flagship technology for use in IVF procedures. Credit: File Just a week into its pivotal deal with global IVF provider Vitrolife, reproductive biotechnology company Memphasys has already received its first order to put its patented Felix system into clinics in Japan.. Last week, Memphasys revealed it had opened a new door by signing an exclusive five-year distribution deal with Vitrolife Japan KK – a subsidiary of the world-renowned Vitrolife Group. It is

Memphasys CEO Alison Coutts, centre, has inked an exclusive distribution deal for the company’s patented Felix system. Credit: File Sydney-based reproductive technology specialist Memphasys has inked an exclusive five-year distribution deal with Vitrolife Japan KK – a subsidiary of the world-renowned Vitrolife Group – to sell and distribute its patented Felix system in Japan. Vitrolife is a global provider of medical devices, consumables and genetic testing services dedicated

Memphasys locks in new patents for flagship IVF treatment

The sperm count of males is reported to have halved over the past 30 years. Credit: File Reproductive biotechnology company Memphasys has received a boost for its flagship Felix system, with the first global study of its kind rating its novel technology as “best available” for recovering high-quality sperm for IVF following the sperm’s cryopreservation. Felix is a medical device that gently separates high-quality sperm from semen for use in IVF programs. In a console that inc

It’s a boy! A remarkable feat for a biotech – a living breathing baby is born